Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
Clinical trial NCT07378644 · RECRUITING
Trial details
- NCT number
- NCT07378644
- Sponsor
- Skyhawk Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-06
- Primary completion
- 2028-12-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.